Immunoglobulin (Ig) class switch DNA recombination (CSR) is the crucial mechanism diversifying the biological effector functions of antibodies. Generation of double-strand DNA breaks (DSBs), particularly staggered DSBs, in switch (S) regions of the upstream and downstream CH genes involved in the specific recombination process is an absolute requirement for CSR. Staggered DSBs would be generated through deamination of dCs on opposite DNA strands by activation-induced cytidine deaminase (AID), subsequent dU deglycosylation by uracil DNA glycosylase (Ung) and abasic site nicking by apurinic/apyrimidic endonuclease. However, consistent with the findings that significant amounts of DSBs can be detected in the IgH locus in the absence of AID or Ung, we have shown in human and mouse B cells that AID generates staggered DSBs not only by cleaving intact double-strand DNA, but also by processing blunt DSB ends generated in an AID-independent fashion. How these AID-independent DSBs are generated is still unclear. It is possible that S region DNA may undergo AID-independent cleavage by structure-specific nucleases, such as endonuclease G (EndoG). EndoG is an abundant nuclease in eukaryotic cells. It cleaves single and double-strand DNA, primarily at dG/dC residues, the preferential sites of DSBs in S region DNA. We show here that EndoG can localize to the nucleus of B cells undergoing CSR and binds to S region DNA, as shown by specific chromatin immunoprecipitation assays. Using knockout EndoG −/− mice and EndoG −/− B cells, we found that EndoG deficiency resulted in a two-fold reduction in CSR in vivo and in vitro, as demonstrated by reduced cell surface IgG1, IgG2a, IgG3 and IgA, reduced secreted IgG1, reduced circle I␥1-C, I␥3-C, I-C, I␣-C transcripts, post-recombination I-C␥1, I-C␥3, I-C and I-C␣ transcripts. In addition to reduced CSR, EndoG −/− mice showed a significantly altered spectrum of mutations in IgH J H -iE DNA. Impaired CSR in EndoG −/− B cells did not stem from altered B cell proliferation or apoptosis. Rather, it was associated with significantly reduced frequency of DSBs. Thus, our findings determine a role for EndoG in the generation of S region DSBs and CSR.
Introduction
Immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM) are central to the maturation of the antibody response. CSR and SHM diversify antibodies in different ways. CSR substitutes an Ig heavy chain (IgH) constant (C H ) region, for instance, C, with a downstream C H region, C␥, C␣ or C, thereby endowing an antibody with different biologi-cal effector functions without changing the structure/specificity of the antigen-binding site. In CSR, double-strand DNA breaks (DSBs) are introduced in the switch (S) regions of an upstream and a downstream C H gene, followed by intrachromosomal and inter-S-S region recombination, entailing the excision of intervening genomic DNA, and variable introduction of point-mutations around recombined S-S region junctions. SHM inserts single nucleotide changes (point-mutations) in V(D)J DNA, thereby providing the substrate for selection by antigen of high-affinity mutants.
DSBs are obligatory intermediates in CSR (Stavnezer et al., 2008; Zan and Casali, 2008) and likely contribute to SHM as well (Bross et al., 2000; Papavasiliou and Schatz, 2000; Bross and Jacobs, 2003; Wu et al., 2003; Zan et al., 2003; Xu et al., 2005) . Both CSR and SHM require activation-induced cytidine deaminase (AID), which is expressed by activated B cells, mainly in germinal centers of peripheral lymphoid organs (Di Noia and Neuberger, 2007; Xu et al., 2007a; Stavnezer et al., 2008; Delker et al., 2009) CSR occurs, in general, in germinal centers in response to T celldependent stimuli, including, engagement of CD40 on B cells by CD154 and cytokines expressed by activated CD4 + T cells (Stavnezer et al., 2008; Pone et al., 2010) . CSR, however, can also be induced in a T cell-independent fashion, e.g., by ligands of Toll-like receptors (TLRs) (Stavnezer et al., 2008; Pone et al., 2010) . CSR requires germline transcription of the intervening (I H ), S and C H regions of the upstream (donor) and downstream (acceptor) C H loci (Wuerffel et al., 2007; Stavnezer et al., 2008) , leading to chromosomal opening and increased accessibility to the S regions that will be targets of recombination. CSR targets DSBs to the 5 -RGYW-3 /5 -WRCY-3 motif, mainly in its 5 -AGCT-3 iteration . Accordingly, AID is specifically targeted to 5 -AGCT-3 rich S regions by 14-3-3 adaptor proteins . It deaminates dC residues to dUs in DNA (Maizels, 2005; Casali et al., 2006; Di Noia and Neuberger, 2007; Xu et al., 2007b; Peled et al., 2008; Stavnezer et al., 2008) , more efficiently when phosphorylated by PKA (Cheng et al., 2009; Vuong et al., 2009) at Serine 38 and in the presence of replication protein A (RPA) (Basu et al., 2008; Rada, 2009) . dUs are deglycosylated by uracil DNA glycosylase (Ung), yielding abasic sites. These are recognized and nicked by an apurinic/apyrimidic endonuclease (APE). Nicking of abasic sites in close proximity on opposite DNA strands give rise to DSBs to initiate CSR (Maizels, 2005; Di Noia and Neuberger, 2007; Stavnezer et al., 2008) . It has been assumed that the absolute requirement of AID in CSR reflects the indispensability of this enzyme in generating DSBs. AID-dependent DSBs have been widely detected in S region DNA by ligation-mediated (LM)-PCR in human and mouse B cells. However, we and other investigators have shown that S region DSBs can also be generated in an AID-independent fashion in human and mouse B cells (Rush et al., 2004; Zan and Casali, 2008) . AID-independent generation of DSBs has been further inferred from the occurrence of intra-S region DNA recombination events in AID-deficient B cell hybridomas (Dudley et al., 2002) , and the frequent translocation of c-myc into S regions in AID-deficient mice (Unniraman et al., 2004) . These findings could also be explained, at least partially, by residual AID expression from the fusion partner that was used for constructing the hybridomas (Dudley et al., 2002) or the possibility that the DNA amplicons used to reveal translocations (Unniraman et al., 2004) could be amplified also from DNA of cells other than B cells (Ramiro et al., 2005) . Nevertheless, a post-cleavage role for AID in CSR has been further suggested by the use of the AID mutant H48A or L49A, the use of Ugi, a specific peptide inhibitor of Ung, and that of an Ung mutant devoid of uracil DNA deglycosylation activity (Begum et al., 2004 (Begum et al., , 2007 Shivarov et al., 2008; Begum et al., 2009 ). As we and others have shown, AID-independent DSBs occur also in V(D)J DNA, where they also target preferentially the mutational 5 -RGYW-3 hotspot (Bross et al., 2000; Papavasiliou and Schatz, 2000; Bross et al., 2002; Papavasiliou and Schatz, 2002a; Bross and Jacobs, 2003; Wu et al., 2003; Zan et al., 2003; Casali and Zan, 2004) . These DSBs are blunt and 5 -phosphorylated, and are processed by AID and Ung, yielding staggered DSB ends, which are characteristic of B cells undergoing CSR and/or SHM Casali and Zan, 2004; Zan and Casali, 2008) . That AID can be recruited to DSBs is suggested by the AID retention rate in the nuclei of B cells treated with DNA break inducers, such as bleomycin, hydrogen peroxide or ␥-rays (Brar et al., 2004) .
How AID-independent DSBs are generated is still unclear. It is possible that these DSBs result from inherent proneness to breakage of S regions, perhaps related to their repetitive nature, as increased susceptibility to breakage is a property of DNA containing repetitive sequences capable of adopting non-canonical DNA conformations (Kataoka et al., 1983; Baar and Shulman, 1995; Chen et al., 2001; Tashiro et al., 2001; Bacolla et al., 2006) . Indeed, CSR is associated with chromatin modifications, including hyperacetylation of histones in S regions and high levels of germline transcriptions through the S regions (Nambu et al., 2003; Wuerffel et al., 2007; Chowdhury et al., 2008; Stavnezer et al., 2008) , that can result in DNA strand opening and increase fragility of S regions. This is particularly true for transcription through the highly repetitive S regions that leads to or enhances the formation of secondary DNA structures such as R-loops, G-loops or stem-loops. These structures arise as result of the high dG/dC content of S regions (Rand G-loops) as well as the high occurrence of palindromic 5 -AGCT-3 (stems of stem-loops) (Baar et al., 1996; Mussmann et al., 1997; Chen et al., 2001; Tashiro et al., 2001; Maizels, 2005; Xu et al., 2010) . R-loops, G-loops and stem-loops contain highly distorted, long and complex, mostly single-strand DNA, which is not only inherently fragile but may undergo cleavage by structure-specific nucleases, such as EndoG, XPF-ERCC1, XPG, GQN1 and exonuclease 1 (Tian and Alt, 2000; Sun et al., 2001; Duquette et al., 2004; Irvine et al., 2005; Vallur and Maizels, 2008) .
EndoG is an abundant nuclease in eukaryotic cells (Irvine et al., 2005) . It is known as one of the endonuclease participating in caspase non-associated apoptosis, but its precise function in mammalian cells is still unclear (Irvine et al., 2005; David et al., 2006) . EndoG is located primarily in the mitochondrial intermembrane space and is likely processed into a nuclear form and exported from mitochondria to the nucleus (Ohsato et al., 2002) . In fact, EndoG was originally identified as a nuclear protein in cells that were not undergoing apoptosis (Ruiz-Carrillo and Renaud, 1987; Gerschenson et al., 1995; Ishihara and Shimamoto, 2006; Yu et al., 2006) . It is a homodimer that cleaves both single-and doublestrand DNA, with an effective R-loop cutting activity (Widlak et al., 2001; Ohsato et al., 2002; Irvine et al., 2005; Huang et al., 2006b; Wu et al., 2009) . EndoG preferentially cleaves DNA at dG/dC residues (Widlak et al., 2001) , which are also the preferential sites of DSBs in S regions (Rush et al., 2004; Schrader et al., 2005; Stavnezer and Schrader, 2006) . It generates DSBs whose free ends are 5 -phosphorylated, like the DSB ends in S and V(D)J region DNA Casali and Zan, 2004; Zan and Casali, 2008) . The features of EndoG prompted us to hypothesize that this endonuclease underlies the generation of AID-independent DSBs in CSR. We tested our hypothesis in a variety of in vivo and in vitro experiments using EndoG −/− mice and EndoG −/− B cells. EndoG-deficient B cells did not show altered proliferation or apoptosis, but showed significantly reduced DSBs in S regions and impaired CSR, in association with altered spectrum of point-mutations in the IgH locus. Thus, our findings define an important role for EndoG in the generation of S region DSBs and CSR.
Materials and methods

Mice
The EndoG −/− mice were generated by Dr. Michael R. Lieber (University of Southern California, Los Angeles, CA) by deleting exon 2 of the EndoG gene, which causes exon 3 to be out of frame, when spliced to exon 1 (Irvine et al., 2005) . No truncated protein was produced from the disrupted allele and no nuclease activity was detected in EndoG −/− mice (Irvine et al., 2005) . These mice were viable and show no age-related or generational abnormalities, nor did they show altered mitochondrial DNA copy number, structure or mutation rate. Their cells showed no obvious changes in nuclear DNA degradation in apoptosis assays (Irvine et al., 2005) . All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of University of California, Irvine, CA.
B and T cells
The monoclonal human 4B6 B cell line was derived from our CSR-and SHM-inducible human monoclonal IgM + IgD + CL-01 B cell line (Zan et al., 1998) by sequential subcloning. 4B6 B cells express significant level of AID and undergo spontaneous CSR to IgG and IgA Zan and Casali, 2008; Xu et al., 2010 
B cell cycle, proliferation and apoptosis
The cell cycle was analyzed by propidium iodide (PI) staining Park et al., 2009) . Cell proliferation was analyzed using the CellTrace TM carboxyfluorescein succinimidyl ester (CFSE) proliferation kit (Molecular Probes, Eugene, OR) Mai et al., 2010) . Cells were washed in serum-free Hank's balanced-salt solution (HBSS, Invitrogen Corp., Carlsbad, CA) and resuspended at a density of 1 × 10 7 cells/ml. After adding an equal volume of 10 M CFSE, the cell suspension was incubated at 37 • C for 12 min and then washed 3 times with RPMI medium containing 10% FBS. Cells were then diluted and cultured with LPS (10 g/ml) from Escherichia coli (serotype 055:B5; Sigma-Aldrich, Inc., St. Louis, MO) in the presence or absence of recombinant mouse interleukin 4 (rmIL-4, 5 ng/ml; R&D Systems, Inc., Minneapolis, MN). They were harvested 2 or 4 days later and analyzed using a FACSCalibur TM flow cytometer (BD Biosciences) .
To analyze B cell proliferation and apoptosis in vivo, mice were injected intraperitoneally with NP 16 -CGG. After 10 days, they were injected intraperitoneally twice within 16 h with bromodeoxyuridine (BrdU) (1 mg) and sacrificed 4 h after the last injection. Cells from the spleen or Peyer's patches were stained with PE-anti-B220 mAb (RA3-6B2) or this mAb together with FITC-PNA. Cells were then fixed and incubated with the permeablization buffer for 15 min in the dark at 4 • C, and then stained with allophycocyanin (APC)-conjugated anti-BrdU mAb using the BrdU Flow Kit (BD Biosciences) Park et al., 2009 ). Cells were analyzed using a FACSCalibur TM flow cytometer. To measure apoptosis, cells from NP 16 -CGG immunized mice were stained with 7-AAD in combination with PE-anti-B220 mAb or APC-anti-CD3 mAb and FITC-PNA and incubated for 30 min at 4 • C in the dark. Cells were then washed and analyzed using a FACSCalibur TM flow cytometer. Terminal deoxynucleotidyl transferase (TdT) mediated dUTP nick-end-labeling (TUNEL) staining with TdT in situ Apoptosis Detection Kit (R&D Systems, Inc.) was also used to quantify apoptosis by counting TUNEL signals (red dots) using the SPOT Software (Diagnostic Instruments, Inc.).
Analysis of CSR
To analyze in vivo CSR, serum IgM, IgG1, IgG3 and IgA concentrations were measured by specific ELISAs , and germinal center (PNA hi B220 + ) B cells expressing IgG1 or IgA were identified using a FACSCalibur TM flow cytometer . To analyze in vitro CSR, B cells were isolated from red blood cells (RBC)-depleted mice splenocytes using a B cell enrichment kit (StemCell Technologies Inc., Canada) and were cultured at 5 × 10 5 cell/ml in FCS-RPMI medium (RPMI-1640 medium (Invitrogen) supplemented with 10% (vol/vol) heat-inactivated FBS (Hyclone), 2 mM l-glutamine and 1× antibiotic-antimycotic mixture (penicillin (100 units/ml), streptomycin (100 mg/ml) and amphotericin B fungizone (0.25 mg/ml); Invitrogen) with 0.05 mM ␤-mercaptoethanol in 48-well plates and stimulated with LPS (10 g/ml) with: nil for CSR to IgG3; rmIL-4 (5 ng/ml; R&D Systems, Inc.) for CSR to IgG1; IFN-␥ (50 ng/ml; PeproTech, Inc., Rocky Hill, NJ) for CSR to IgG2a; or TGF-␤ (1 ng/ml; R&D Systems, Inc.), rmIL-4 (5 ng/ml), and rmIL-5 (5 ng/ml; R&D Systems, Inc.) and anti-IgD mAb-dextran (3 ng/ml; provided by Dr. Snapper, C.M., Uniformed Services University of the Health Sciences, Bethesda, MD) for CSR to IgA. Cells were collected on day 3 for analysis of germline I H -C H , circle I H -C and post-recombination I-C H transcripts, and on day 4 for analysis of surface Igs after staining with FITC-labeled rat mAb to mouse IgG1 (A85-1), mouse IgG2a (R19-15), mouse IgG3 (R40-82) or mouse IgA (C10-3), or PE-labeled rat mAb to mouse CD45R (B220; RA3-6B2; all from BD Biosciences). IgG1 concentration in culture supernatants of LPS and rmIL-4-stimulated B cells were measured by specific ELISA ).
Quantitative real-time RT-PCR (qRT-PCR) and semiquantitative RT-PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA) according to the manufacturer's protocol. Residual DNA was removed by treatment with DNase I (Invitrogen Corp., Carlsbad, CA). First strand cDNAs were synthesized from equal amounts of total RNA (2 g) using the SuperScript TM Preamplification System and oligo (dT) primer (Invitrogen Corp.). The expression of Aicda, germline I H -C H , circle I H -C and postrecombination I-C H transcripts was quantified by real-time qRT-PCR using appropriate primers ). Real-time qRT-PCR analysis was performed using an DNA Engine Opticon 2 Real-Time PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA) to measure SYBR-green (DyNAmo HS SYBR Green, New England Biolabs, Inc., Ipswich, MA) incorporation with the following protocol: 50 • C for 2 min, 95 • C for 10 min, 40 cycles of 95 • C for 10 s, 60 • C for 20 s, 72 • C for 30 s, 80 • C for 1 s, and data acquisition at 80 • C, and 72 • C for 10 min. Melting curve analysis was performed from 72 to 95 • C and samples were incubated for another 5 min at 72 • C. The
Ct method was used for data analysis. In some cases, V H DJ H -C and GAPDH/Gapdh transcripts were analyzed by specific semiquantitative RT-PCR, involving serial twofold diluted template cDNA so there was a nearly linear relationship between the amount of cDNA used and the intensity of the PCR product (Zan and Casali, 2008; Park et al., 2009 ).
Cell fractionation and immunoblotting
B cells (3 × 10 7 ) were washed with PBS after centrifugation through a Ficoll ® gradient to clear debris and dead cells, and resuspended in hypotonic buffer (20 mM Tris pH 7.5, 10 mM KCl, 10 mM MgCl 2 , 1× protease inhibitors mix (Sigma-Aldrich)) on ice for 10 min. After adding Nonidet P-40 (1% final concentration), the mixture was vortexed and then placed on ice for 1 min. Following centrifugation at 1000 × g for 5 min, the supernatant was clarified by centrifugation (5 min at 20,000 × g) and collected as cytoplasmic fraction; the pellet was resuspended in S1 solution (0.25 M sucrose, 5.0 mM MgCl 2 ) and layered on a sucrose cushion S2 (0.35 M sucrose, 5 mM MgCl 2 ), before being centrifuged at 3000 × g for 5 min. The pellet was resuspended in S1 solution, re-centrifuged, resolubilized and then collected as nuclear fraction. For immunoblotting analysis, equal amount (25 g) of proteins were separated through 10% SDS-PAGE. Proteins were transferred onto polyvinylidene difluoride membranes (Bio-Rad Laboratories) overnight (30 V) at 4 • C. The blocked membranes were incubated overnight at 4 • C with rabbit Ab to Cox4 isoform 1 (NB110-39115, Novus Biologicals), mouse mAb to PCNA (PC-10, BD Biosciences) or mouse mAb to histone H1 (AE-4, Santa Cruz Biotechnology). The membranes were then incubated with horseradish peroxidase (HRP)-conjugated secondary Abs. After washing with PBS-Tween 20 (0.05%), bound HRP-conjugated Abs or mAbs were detected using Western Lightning ® Plus-Enhanced Chemiluminescence reagents (PerkinElmer Life and Analytical Sciences).
Chromatin immunoprecipitation (ChIP) assays
B cells (5 × 10 7 ) were treated with 1% formaldehyde for 10 min at 25 • C to cross-link chromatin. After washing with cold PBS containing protease inhibitors (Roche, Basel, Switzerland), chromatin was separated using nuclear lysis buffer (10 mM Tris-HCl, 1 mM EDTA, 0.5 M NaCl, 1% Triton-X-100, 0.5% sodiumdeoxycholate, 0.5% sarcosyl, pH 8.0) and resuspended in IP-1 buffer (20 mM Tris-HCl, 200 mM NaCl, 2 mM EDTA, 0.1% sodiumdeoxycholate, 0.1% SDS, protease inhibitors). The chromatin was sonicated to yield approximately 200-1000 bp DNA fragments. DNA fragments were precleared with agarose beads bearing protein G (Santa Cruz Biotechnology, Santa Cruz, CA) and then incubated with rabbit IgG to EndoG (FL-297, Santa Cruz Biotechnology) (Zhao et al., 2010) or mouse IgG1 mAb to AID (clone ZA001, Invitrogen) . After overnight incubation at 4 • C, immune complexes were isolated using beads bearing protein G, eluted with Elution buffer (50 mM Tris-HCl, 0.5% SDS, 200 mM NaCl, 100 g/ml Proteinase K, pH 8.0), and then incubated at 65 • C overnight to reverse the formaldehyde cross-links. DNA was recovered by phenol/chloroform extraction followed by ethanol precipitation, and then resuspended in TE buffer (10 mM Tris-HCl, pH 8.0, 1.0 mM EDTA). Recovered DNA was specified by PCR using the following oligonucleotide primers: human S, forward 5 -ATGGAAGCCAGCCTGGCTGT-3 and reverse 5 -CAGTTAGTGCAGCCAAGCCCTAGCTCAG-3 ; human S␥1, forward 5 -ACCCTATGCAGTGTCTGGCCCCTC-3 and reverse 5 -AG-TCAGCACAGTCCAGTGTCTCTAG-3 ; human C, forward 5 -CACG-TGGTGTGCAAAGTCCAGCACC-3 and reverse 5 -ACGCCAGACCCC-ACCTGCTT-3 ; human V H DJ H , forward 5 -CAGGGAAGGGGCTGGAG-TGG-3 and reverse 5 -AGGAAACCCCACAGGCAGTAGCA-3 ; mouse S, forward 5 -CTGAGGTGATTACTCTGAGGT-3 and reverse 5 -CTC-CAGAGTATCTCATTTCAG-3 ; mouse S␥1, forward 5'-GAGCCAAGG-TAGGTGGAATGTG-3 and reverse 5 -C TGTGACTGCTTAGAATCCC-CAAC-3 ; mouse C, forward 5 -GGCTTCTACTTTACCCACAGCATC-3 and reverse 5 -CATACACAGAGCAACTGGACACCC-3 .
DNA breaks
The biotin-labeling DNA break assays were performed as reported (Begum et al., 2009; Doi et al., 2009) . Live B cells were separated through a Ficoll ® gradient, followed by fixation, permeabilization and in situ DNA end-labeling with biotin-16-dUTP (bio-dUTP) using TdT to detect overall DNA cleavages, including single-strand breaks (SSBs) and DSBs, or ligated with the biotinylated double-strand anchor linker BW (bio-linker) with or without pre-treatment of T4 DNA polymerase and dNTP to detect blunt or total (blunt plus staggered) DSBs Zan and Casali, 2008; Begum et al., 2009; Doi et al., 2009) . Genomic DNA was prepared using QIAamp DNA Mini Kit (Qiagen, Inc.) and digested with Pvu II and Pst I. Biotin-labeled DNA fragments were captured by streptavidin magnetic beads (Promega Corp., Madison, WI). For quantification of broken DNA, biotin-labeled DNA was serially twofold diluted and used as template for S, S␥1 and C DNA amplification. PCR amplifications were performed at 94 • C for 30 s, 55 • C for 45 s, 72 • C for 30 s for 32 cycles using GoTaq ® Hot Start Polymerase (Promega Corp.) and mouse S, S␥1 or C specific forward and reverse primers described above.
S-S DNA junction sequences
Genomic DNA was prepared from B cells cultured for 4 days with LPS and rmIL-4. S-S␥1 junction DNA were amplified using two sequential rounds of specific PCR (Wu et al., 2006) using Phusion TM high-fidelity DNA polymerase (New England Biolabs, Inc.) and the following nested oligonucleotide primers: forward 5 -AACTCTCCAGCCACAGTAATGACC-3 and reverse 5 -CTGTAACCTACCCAGGAGACC-3 for the first round; forward 5 -ACGCTCGAGAAGGCCAGCCTCATAAAGCT-3 and reverse 5 -GTCGAATTCCCCCATCCTGTCACCTATA-3 for the second round. The first and second rounds of PCR were performed at 94 • C for 45 s, 55 • C for 45 s, 72 • C for 4 min, 30 cycles. PCR DNA products were purified using Qiaquick PCR purification kit (Qiagen, Inc.) and cloned into pCR-Blunt II-TOPO ® vector (Invitrogen, Corp.) for sequencing. Sequence alignment was done by comparing the sequences of PCR products with S and S␥1 genomic sequences using NCBI blast http://www.ncbi.nih.gov/BLAST.
Somatic mutations in intronic V J558 DJ H 4-iE DNA
Peyer's patches germinal center (PNA hi B220 + ) B cells were obtained from one pair of 10 week-old and one pair of 28 week-old non-intentionally immunized littermate EndoG −/− and EndoG +/+ mice and were used for analysis of somatic mutations in the intronic DNA downstream of rearranged V J558 DJ H 4 genes . The intronic heavy chain region downstream of rearranged V J558 DJ H was amplified from genomic DNA by nested PCR using Phusion TM high-fidelity DNA polymerase and primer pairs: forward 5 -AGCCTGACATCTGAGGAC-3 and reverse 5 -TCTGATCGGCCATCTTGACTC-3 for the first round PCR and forward: 5 -CATCTGAGGACTCTGCNGTCTAT-3 and reverse 5 -CCTCACTCCCATTCCTCGGTTAAA-3 for the second round PCR. Reaction conditions for both the first and second round PCR were 30 cycles of 98 • C for 15 s, 58 • C for 45 s and 72 • C for 1 min. PCR products were cloned into the pCR-Blunt II-TOPO ® vector (Invitrogen, Corp.) and sequenced. Only sequences from rearrangements involving J H 4-iE were analyzed. Sequences were analyzed with MacVector software (MacVector, Inc., Cary, NC).
Statistical analyses
The differences in frequency and spectrum of mutations in EndoG −/− and EndoG +/+ mice were analyzed using the 2 test. The differences in Ig titers were analyzed using paired t-tests.
Results
EndoG localizes to the nucleus and is specifically recruited to S regions
EndoG localizes primarily in the mitochondrial inter-membrane space and can translocate to the nucleus in caspase-independent apoptosis (David et al., 2006) . In addition, EndoG can translocate to the nucleus in the absence of significant apoptosis and plays a role in DNA recombination and cellular proliferation (Huang et al., 2006a) . To test the hypothesis that EndoG can localize to the nucleus in B cells undergoing CSR, we stimulated mouse B cells with LPS and rmIL-4, which induce CSR to IgG1, or with anti-IgD mAb-dextran EndoG is recruited to S region but not CH region DNA. Left and middle panels: cross-linked chromatin was precipitated from human spontaneously switching 4B6 or C57BL/6 mouse spleen B cells stimulated with LPS and rmIL-4, or anti-IgD mAb-dextran and rmIL-4 for 2 days using a rabbit IgG Ab specific for EndoG or preimmune control rabbit IgG. The precipitated DNA was specified by PCR using human or mouse VHDJH, S, S␥1 or C primers; right panels: VHDJH-C and GAPDH/Gapdh transcripts in 4B6, LPS and rmIL-4-or anti-IgD mAb-dextran and rmIL-4-stimulated mouse spleen B cells were amplified by RT-PCR using two-fold diluted template cDNA. (C) EndoG-deficiency does not alter the recruitment of AID to S regions. Cross-linked chromatin was precipitated from EndoG +/+ and EndoG −/− B cells stimulated with LPS and rmIL-4 for 2 days using a IgG1 mAb specific for AID or a control mouse IgG1. The precipitated DNA was specified by PCR using mouse S or C primers. and rmIL-4, which induce B cell proliferation but not CSR, and, after a 2-day culture, analyzed EndoG expression and localization by specific immunoblotting. EndoG localized to both the cytoplasm and the nucleus of B cells treated with anti-IgD mAb-dextran and rmIL-4, but its density at both locations increased significantly after stimulation with LPS and rmIL-4 ( Fig. 1(A) ). The purity of the cytoplasm and nuclear fractions used for immunoblotting was confirmed by the detection of PCNA, which is known to localize both cytoplasm and nucleus, in both cytoplasm and nucleus fractions, and the absence of cytoplasmic protein Cox4 or nuclear protein histone H1 in the nucleus and cytoplasm fractions, respectively, of B cells. In addition, ChIP assays showed that EndoG was recruited to S and S␥1 but not C DNA in both spontaneously switching human 4B6 B cells, and mouse B cells stimulated with LPS and rmIL-4 ( Fig. 1(B) ). In LPS and rmIL-4-stimulated mouse B cells, a small amount of EndoG was also recruited to V H DJ H region DNA. The lack of recruitment of EndoG to C DNA did not result from lack of transcription of this region, as indicated by the high V H DJ H -C transcript levels. Further, the recruitment of EndoG to S and V H DJ H region DNA was significantly less in B cells treated with anti-IgD mAb-dextran and rmIL-4 as compared to B cells stimulated with LPS and rmIL-4. Finally, the absence of EndoG did not affect recruitment of AID to S region DNA, as indicated by lack of alteration in AID recruitment to S in EndoG −/− B cells stimulated with LPS and rmIL-4 ( Fig. 1(C) ).
EndoG −/− mice show normal B and T cells, and germinal center formation
To directly address the role of EndoG in CSR, we turned to EndoG −/− mice and EndoG −/− B cells. As EndoG possibly modulates cell division, by virtue of its role in apoptosis, we first examined EndoG −/− mice for any defect in B and T cell development or proliferation and germinal center formation.
In EndoG −/− mice, the size of the spleen and the number and size of Peyer's patches were similar to those of EndoG +/+ mice (not shown). Moreover, the number of B and T cells, the proportion of CD4 + T cells in the spleen and Peyer's patches were also comparable to those of EndoG +/+ mice ( Fig. 2(A) and (B) ). To examine whether EndoG deficiency has effect on germinal center formation, we immunized 8-10 weeks old littermate EndoG −/− and EndoG +/+ mice with NP 16 -CGG. Mice were sacrificed and spleen sections were stained with FITC-PNA and PE-anti-B220 mAb 14 days later ). The number and architecture of germinal centers in the spleen of EndoG −/− mice were comparable to those of EndoG +/+ mice ( Fig. 2(C) ). In addition, in EndoG −/− mice, the proportion of germinal center (B220 + PNA hi ) B cells in both spleen and Peyer's patches, the proportion of proliferating B cells, as shown by in vivo incorporation of the thymidine analog BrdU, were not significantly different from those of EndoG +/+ mice ( Fig. 2(D) and (E)).
As EndoG can be an apoptosis-related protein, we examined whether EndoG deficiency affects B cell apoptosis/viability, cell cycle or proliferation. The proportion of apoptotic (TUNEL + ) cells in the spleen germinal center (PNA + ) cells of EndoG −/− mice was comparable to that of EndoG +/+ mice, as shown by the immunofluorescent staining (Fig. 3(A) and (B) ). Peyer's patches and spleen cells were further stained with APC-anti-CD3 mAb, PE-anti-B220 mAb and 7-AAD, and live/dead T and B cells were analyzed by flow cytometry. The proportion of apoptosis/necrosis (7-AAD + ) T cells (CD3 + ) and B cells (B220 + ) in EndoG −/− mice were comparable to those in EndoG +/+ mice (Fig. 3(C) terms of cell cycle, as analyzed by staining with propidium iodide (PI), and cell division rate, as measured by incorporation of the vital dye CFSE (Fig. 3 (E) and (F)). Thus, EndoG −/− mice displayed normal B and T cells numbers and viability, germinal center formation and B cells proliferation.
EndoG deficiency impairs CSR in vivo and in vitro
We next examined the in vivo CSR in EndoG −/− mice. In unimmunized EndoG −/− mice, serum IgM concentration were normal (p = 0.62). However, the average serum IgG1 concentration was reduced by almost 60% as compared to their EndoG +/+ counterparts (p = 0.0019, Fig. 4(A) ). In addition, serum IgG3 and IgA concentrations were also reduced, albeit less significantly (p = 0.17 and 0.35, respectively), in these mice. Because of the long half-life of plasma cells and antigen-mediated selection, Igs can accumulate in the circulation in significant amounts even when CSR is substantially compromised (Rada et al., 2002) . Hence, the lack of reduction of total serum IgG titers in a previous report (Irvine et al., 2005) did not necessarily reflect a lack of CSR impairment. We immunized 10 week-old EndoG −/− and EndoG +/+ littermate mice with NP 16 -CGG. 14 days later, we harvested the spleen cells and stained them with FITC-conjugated PNA, PE-labeled anti-B220 mAb and APC-labeled anti-IgG1 mAb. We found that the proportion of sIgG1 + B cells among germinal center (PNA hi B220 + ) B cells in EndoG −/− mice was reduced by more than 34% as compared to their EndoG +/+ littermates (2.8% vs. 4.3%, Fig. 4(B) ). Likewise, in the Peyer's patches of unimmunized 12 week-old EndoG −/− mice, the number of germinal center (PNA hi B220 + ) B cells switched to IgA was reduced by more than 53% (6.5% vs. 13.9%, Fig. 4(C) ).
To further determine the impact of the EndoG deficiency on CSR, we stimulated spleen B cells with LPS (to induce switching to IgG3), LPS and rmIL-4 (to induce switching to IgG1), LPS and IFN-␥ (to induce switching to IgG2a) or LPS in the presence of TGF-␤1, rmIL-5, rmIL-4 and anti-IgD mAb-dextran (to induce switching to IgA). After 4 days of culture, the proportion of live EndoG −/− (7-AAD − B220 + ) B cells positive for surface IgG1, IgG2a, IgG3 or IgA was reduced by 51%, 37%, 53% or 40%, respectively, as compared to that of the corresponding EndoG +/+ B cells (Fig. 4(D LPS and rmIL-4 was 44% lower than their EndoG +/+ counterparts (p = 0.0009, Fig. 4(E) ). Impaired CSR in EndoG −/− B cells was not due to altered proliferation, as after 2 or 4 days of culture with LPS or LPS plus rmIL-4, EndoG −/− B cells completed the same number of divisions as their EndoG +/+ counterparts did (Fig. 3(F) ). However, the percentage of IgG1 positive B cells was twofold greater among EndoG +/+ B cells than EndoG −/− B cells that had undergone the same number of divisions (Fig. 4(F) ). Further, the reduced CSR in EndoG −/− B cells was not due to impairment of Aicda or germline transcription of the intervening heavy-chain (I H ) region and constant heavy-chain (C H ) region (I H -C H ), which is necessary for CSR. Real-time qRT-PCR showed that the abundance of Aicda and germline I␥1-C␥1, I␥3-C␥3, I-C and I␣-C␣ transcripts in EndoG −/− B cells stimulated for 3 days with LPS alone or LPS plus cytokines was comparable to that in their EndoG +/+ B cell counterparts (Fig. 4(G) ), whereas circle I␥1-C, I␥3-C, I-C and I␣-C transcripts, and post-recombination I-C␥1, I-C␥3, I-C and I-C␣ transcripts, which are generated only after a CSR event, were significantly reduced in EndoG −/− B cells. Thus, EndoG deficiency impairs CSR without affecting Aicda expression or germline I H -C H transcription.
EndoG deficiency reduces DSBs in S region DNA
To further understand whether EndoG contributes to CSR by generating DNA breaks, we analyzed blunt and total (blunt and staggered) DSBs as well as overall DNA cleavages (SSBs and DSBs) in S regions in LPS and rmIL-4-stimulated EndoG −/− and EndoG +/+ EndoG +/+ and EndoG −/− spleen B cells stimulated with LPS and rmIL-4 for 2 days or unstimulated Peyer's patches B cells were analyzed for DNA break ends. DNA was labeled in situ with biotin-dUTP using TdT (to detect overall DNA cleavages, including both SSBs and DSBs), or biotin-labeled BW linker (bio-linker) with or without pre-treatment of T4 DNA polymerase and dNTP (to detect total, including 5 -phosphorylated blunt and staggered DSBs, or 5 -phosphorylated blunt DSBs, respectively). S, S␥1 and C DNA were amplified from serially twofold diluted biotin-labeled DNA and the input DNA by PCR. Data are representative of three independent experiments. B cells, as well as EndoG −/− and EndoG +/+ Peyer's patch B cells. For the detection of blunt and total DSBs, DNA ends were in situ ligated with the bio-linker with or without pre-treatment with T4 DNA polymerase and dNTP Zan and Casali, 2008; Begum et al., 2009; Doi et al., 2009) . To evaluate the overall degree of DNA cleavage, DNA ends were in situ labeled by bio-dUTP using TdT (Begum et al., 2009; Doi et al., 2009) . After in situ bio-linker ligation or bio-dUTP labeling, DNA extraction and digestion with restriction endonuclease, the biotin-labeled DNA fragments were isolated with streptavidin magnetic beads, serially twofold diluted and used as templates in specific PCR to amplify S, S␥1, and, potentially, C regions. Blunt and total DSBs as well as the overall DNA cleavages were readily detected in S and S␥1 regions EndoG +/+ B cells (Fig. 5) . The S region DNA breaks were significantly reduced in EndoG −/− B cells. Consistent with our previous findings by LM-PCR Zan and Casali, 2008) , no breaks were detected in C region DNA, further supporting the specificity of these findings. Thus, EndoG plays an important role in the generation of S region DNA breaks in B cells undergoing CSR.
S-S region DNA junctions in EndoG −/− B cells
To further address the role of EndoG in CSR, we sequenced the recombined S-S␥1 DNA junctions of LPS and rmIL-4-stimulated EndoG −/− and EndoG +/+ B cells and compared them with the respective S and S␥1 genomic templates to determine the degree of overlap (microhomology) of the upstream S and downstream S␥1 regions, and the frequency of inserted nucleotides between the upstream S and downstream S␥1 DNA ends (insertions), as microhomologies and insertions are associated with CSR (Wu et al., 2006) . Analysis of 13 unique S-S␥1 sequences in B cells from 2 EndoG −/− and 2 EndoG +/+ littermates showed that 2 out of 13 S-S␥1 DNA junctions from EndoG +/+ B cells and 1 out of 13 S-S␥1 DNA junctions from EndoG −/− B cells contain nucleotides insertions; 9 out of 13 S-S␥1 DNA junctions from EndoG +/+ B cells and 10 out of 13 S-S␥1 DNA junctions from EndoG −/− B cells contain microhomologies (Fig. 6 ). In addition, one S-S␥1 DNA junction (E+31) from EndoG +/+ B cells contains an insertion consisting of 17 bp and 38 bp S sequences from different areas of S DNA. Although the number of nucleotides insertions and the average length of microhomologies in S-S␥1 DNA junctions in EndoG +/+ B cells were slightly higher than that of EndoG −/− B cells (2 or 15.4% vs. 1 or 7.7%, and 3.3 nucleotides vs. 2 nucleotides, respectively), the difference in S-S region DNA junctions between EndoG +/+ and EndoG −/− B cells was not significant.
3.6. EndoG −/− mice display altered spectrum of somatic point-mutations
To determine whether the reduced CSR and DNA cleavages in the absence of EndoG were associated with altered somatic pointmutations in the IgH locus, we analyzed the J H 4-iE sequence downstream of rearranged V J558 DJ H 4 DNA in germinal center (PNA hi B220 + ) B cells from Peyer's patches of one pair of 10 week-old and one pair of 28 week-old non-intentionally immunized littermate EndoG −/− and EndoG +/+ mice. In these mice, the proportions of Peyer's patch PNA hi B220 + B cells were comparable (Fig. 2(B) ). The intronic J H 4-iE DNA downstream of V J558 DJ H 4 rearrangement, which is targeted by SHM but is not subjected to positive or negative selection pressure, was amplified using a nested PCR involving V J558 FR3 forward primers and reverse primers specific for sequences downstream of J H 4. We chose to analyze only the sequences downstream of V J558 DJ H 4 rearrangements, as V H DJ H rearrangements involving different J H genes place the J H -iE intron at different distances from the V H promoter and may result in different mutation rates.
Analysis of 83 J H 4-iE intronic DNA sequences (720 bp) from a 10 week-old EndoG −/− mouse and 84 J H 4-iE intronic DNA sequences from its EndoG +/+ littermate showed a decrease in mutations in the EndoG −/− mouse by 39.2% (1.76 × 10 −3 vs. 1.07 × 10 −3 change/base, p = 0.0001) (Fig. 7(A) ). The decrease of mutation frequency became less significant in older mice, in which the overall mutation frequency is in general greatly increased. Analysis of 58 and 54 J H 4-iE intronic DNA sequences from a pair of 28 week-old EndoG −/− and EndoG +/+ littermate mice showed a decrease in mutations in EndoG −/− mouse by over 14.3% (4.53 × 10 −3 vs. 3.88 × 10 −3 change/base, p = 0.0589). Absence of EndoG also resulted in an overall 27.5% reduction in the proportion of mutations at dG/dC (p = 0.0001, Fig. 7 (B) ) and a reduction in transitions to transversions ratio (p < 0.0001), mainly due to decreased dA/dT transitions (p = 0.0001). Thus, EndoG deficiency only slightly reduces the frequency of somatic point-mutations, but significantly alters the mutational spectrum.
Discussion
Generation of DSBs, particularly staggered DSBs in S regions is critical for CSR. We and others have shown in the human and mouse IgH locus that AID generates staggered DSBs not only by cleaving intact double-strand DNA, but also by processing blunt DSB ends generated independently of AID (Bross et al., 2002; Papavasiliou and Schatz, 2002b; Bross and Jacobs, 2003; Wu et al., 2003; Casali and Zan, 2004; Zan and Casali, 2008) . How these AID-independent DSBs are generated and what is their role in CSR has been a longstanding question.
We presented here evidence indicating that EndoG introduces a significant proportion of DSBs in S region DNA and contributes to the overall CSR process. We showed that EndoG, which cleaves DNA primarily at dG/dC-the preferential sites of DSBs in S region DNA, can translocate to the nucleus, where it binds to S region DNA in B cells undergoing CSR. EndoG deficiency resulted in decreased CSR. This was associated with significantly reduced DNA cleavages, including DSBs, in S regions. The effects of EndoG deficiency were not limited to the S region DNA, but extended to other areas of the IgH locus, as shown by the altered mutation spectrum in J H 4-iE intronic DNA, including significant decrease in mutations at dG/dC. Thus, our findings outline an important role of EndoG in CSR and, possibly, SHM. They, however, cannot rule out the possibility that factor(s) other than AID and EndoG may also be involved in the generation of DSBs. A more precise role of EndoG in the generation of DSBs would be addressed using double knockout EndoG −/− Aicda −/− mice.
It has been assumed that the absolute requirement for AID in CSR reflects the indispensability of this enzyme in generating DSBs by deaminating S region DNA. This is further supported by the preferential localization of DSBs at dC:dG base-pairs in the 5 -RGYW-3 /5 -WRCY-3 motif, the target of AID (Schrader et al., 2005) . However, a post-cleavage role for AID in CSR has been indicated by the occurrence of unignorable amounts of "background" DSBs in S regions DNA of AID-or Ung-deficient B cells (Rush et al., 2004; Zan and Casali, 2008) . In addition, intra-S region DNA recombination events have been suggested to occur in AID-deficient B cell hybridomas (Dudley et al., 2002) and in vivo c-myc translocations into S regions were putatively detected in AID-deficient mice (Unniraman et al., 2004; Unniraman and Schatz, 2006) . Finally, DSBs have been shown to occur in V(D)J DNA of AID-deficient mouse B cells (Bross et al., 2002; Papavasiliou and Schatz, 2002b; Bross and Jacobs, 2003) and in human B cells, in which the AID activity was inhibited by a dominant negative AID mutant . EndoG was first identified in the budding yeast S. cerevisiae as Nuc1p; Nuc1p displays endo/exonuclease activities and regulates life and death in yeast (Buttner et al., 2007) . In yeast, Nuc1p has been suggested to play roles in caspase-independent apoptosis, mitochondrial DNA replication, DNA recombination and cell proliferation (Burhans and Weinberger, 2007) . In mammals, EndoG has been thought to exert similar functions. Knockout of EndoG, however, did not result in obvious abnormalities in mice, thereby questioning the putative vital function(s) of this endonuclease in mammals (Irvine et al., 2005; David et al., 2006) . Accordingly, EndoG deficiency did not alter B cell viability, cycle or proliferation in our hands. The apparently normal phenotype of EndoG −/− mice can be explained by the finding that in addition to EndoG, mammalian cells contain other factors, such as members of the paralogous ExoG-protein subfamily, which display complementary and partially overlapping enzymatic activities with EndoG (Cymerman et al., 2008) . Such factors could have simply stood in for at least some of the lost EndoG functions in EndoG −/− mice.
As we show here, in the absence of EndoG, overall DNA cleavages, including DSBs, in S and S␥1 regions were significantly reduced. Reduced DSBs were associated with reduced CSR, indicating that EndoG is involved in the generation of at least some DSBs. EndoG can cleave both single-and double-strand DNA at comparable rates (Cymerman et al., 2008) to generate SSBs and DSBs. Some DSBs may stem from SSBs generated by EndoG and AID on the opposite strands. Besides EndoG, higher eukaryote cells contain its paralog ExoG, which possesses 5 -3 exonuclease activity; EndoG and ExoG may function together to cleave double-strand DNA (Cymerman et al., 2008) . In addition to AID-dependent DSBs, many DSBs in the IgH locus are generated in an AID-independent fashion (Bross et al., 2002; Papavasiliou and Schatz, 2002b; Bross and Jacobs, 2003; Zan et al., 2003; Zan and Casali, 2008) . These DSBs are blunt and 5 -phosphorylated, and are processed by AID to yield staggered end DBS in B cells undergoing CSR/SHM Casali and Zan, 2004; Zan and Casali, 2008) . DSBs arising independently of AID, whether by intervention of EndoG or other factors, would constitute only a first step in the unfolding of the overall CSR process. Such DSBs would be processed by AID (Zan and Casali, 2008) to ensure that the ends are staggered for CSR. Ligation of DSB staggered ends would then generate the microhomologies, nucleotide insertions and point-mutations that characteristically occur in and around intra-S region or inter S-S region recombinations (Chen et al., 2001; Honjo et al., 2002; Wu et al., 2006; Zan and Casali, 2008) .
CSR is associated with transcription that may result in R-loop formation to give rise to the (functional) single-strand DNA needed for AID deamination activity. R-loop formation initiates with a Rloop initiation zone (RIZ), which is, in general, a dG-cluster. A SSB at a dG-cluster can function as a strong RIZ (Roy et al., 2010) . In addition to DSBs, SSBs can be generated independently of AID in S regions (Arudchandran et al., 2004 (Arudchandran et al., , 2008 . These SSBs may be created by EndoG and would lead to R-loop formation. EndoG possesses an effective R-loop cutting activity, which can lead to the generation of DNA cleavages (Côté and Ruiz-Carrillo, 1993; Widlak et al., 2001; Ohsato et al., 2002; Irvine et al., 2005) . These R-loops can be targeted by EndoG or AID to yield more DNA cleavages, including SSBs and, therefore, more R-loop formation. This may function as a nick and R-loop amplification intermediate. The specific targeting of EndoG to S region DNA would be further established by chromatin modification, such as phosphorylation of histones, in S regions. It has been shown that phosphorylation of histone H2B is necessary for yeast EndoG to attack DNA (Buttner et al., 2007) . Indeed, phosphorylation of histone H2B within Ig S and V regions correlates tightly with CSR and SHM (Odegard et al., 2005) . The precise mechanisms of this targeting process and the cleavage co-factors involved in the generation of AID-independent DSBs need further analysis. 
